In Vitro and In Vivo Transfer and Expression of Human Surfactant SP-A- and SP-B-Associated Protein cDNAs Mediated by Replication-Deficient, Recombinant Adenoviral Vectors

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Human Gene Therapy

• Publication date

  1995-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/hum.1995.6.3-277PMID 7779911
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pulmonary alveolar proteinosis: an uncommon cause of chronic neonatal respiratory distress.

  2015cited by this paper
• Lung surfactant: A biotechnological challenge

  2007cited by this paper
• Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots

  2007cited by this paper
• A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds.

  1994cited by this paper
• Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses.

  1994cited by this paper
• Comparison of the Opsonic Activity of Human Surfactant Protein A for Staphylococcus aureus and Streptococcus pneumoniae with Rabbit and Human Macrophages

  1993cited by this paper
• Surfactant and the adult respiratory distress syndrome.

  1993cited by this paper
• Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage.

  1993cited by this paper
• Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages.

  1993cited by this paper
• Decreased surfactant protein A in patients with bacterial pneumonia.

  1993cited by this paper
• Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer.

  1993cited by this paper
• Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis.

  1993cited by this paper
• Differential sensitivity to fibrinogen inhibition of SP-C- vs. SP-B-based surfactants.

  1992cited by this paper
• Differential extraction for the rapid purification of bovine surfactant protein B.

  1992cited by this paper
• Surfactant protein A in the course of respiratory distress syndrome

  1992cited by this paper
• Ovine pulmonary surfactant induces killing of Pasteurella haemolytica, Escherichia coli, and Klebsiella pneumoniae by normal serum

  1992cited by this paper
• In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.

  1992cited by this paper
• Specific binding of surfactant apoprotein SP-A to rat alveolar macrophages.

  1992cited by this paper
• Congenital pulmonary alveolar proteinosis: failure of treatment with extracorporeal life support.

  1992cited by this paper
• Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.

  1992cited by this paper
• Characterization of a second human pulmonary surfactant-associated protein SP-A gene.

  1992cited by this paper
• Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages.

  1991cited by this paper
• Activity of pulmonary surfactant after blocking the associated proteins SP-A and SP-B.

  1991cited by this paper
• [Lung transplantation].

  1991cited by this paper
• Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo.

  1991cited by this paper
• Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome.

  1991cited by this paper
• Immunogenicity of surfactant. I. Human alveolar surfactant

  1991cited by this paper
• Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A.

  1990cited by this paper
• Expression of mature pulmonary surfactant-associated protein B (SP-B) in Escherichia coli using truncated human SP-B cDNAs.

  1990cited by this paper
• Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro.

  1990cited by this paper
• Effect of canine surfactant protein (SP‐A) on the respiratory burst of phagocytic cells

  1990cited by this paper
• Structure and Organization of the Gene Encoding Human Pulmonary Surfactant Proteolipid SP-B

  1989cited by this paper
• Pulmonary surfactant apoproteins: a review of protein and genomic structure.

  1989cited by this paper
• Processing of hydrophobic pulmonary surfactant protein B in rat type II cells.

  1989cited by this paper
• Pulmonary alveolar proteinosis in a newborn

  1989cited by this paper
• A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5.

  1988cited by this paper
• Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.

  1988cited by this paper
• Alveolar type II cells express a high-affinity receptor for pulmonary surfactant protein A.

  1988cited by this paper
• Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity.

  1987cited by this paper
• Surfactant-associated protein inhibits phospholipid secretion from type II cells.

  1987cited by this paper
• Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of liposomes by type II cells.

  1987cited by this paper
• cDNA and deduced amino acid sequence of human pulmonary surfactant-associated proteolipid SPL(Phe).

  1987cited by this paper
• Pulmonary surfactant and its components inhibit secretion of phosphatidylcholine from cultured rat alveolar type II cells.

  1987cited by this paper
• Reconstitution of surfactant activity by using the 6 kDa apoprotein associated with pulmonary surfactant.

  1986cited by this paper
• Dynamics of the gas‐surface interaction and the mechanism of condensation of RbI molecules incident on NaCl (100) surfaces

  1985cited by this paper
• Identification of canine pulmonary surfactant-associated glycoprotein A precursors.

  1985cited by this paper
• Increased surface tension favors pulmonary edema formation in anesthetized dogs' lungs.

  1979cited by this paper
• Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

  1977cited by this paper
• Lung surfactant.

  1974cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper
• Surface properties in relation to atelectasis and hyaline membrane disease.

  1959cited by this paper
• Pulmonary alveolar proteinosis.

  1958cited by this paper

• Lung surfactant as a biophysical assay for inhalation toxicology

  2022cites this paper
• A lung tropic AAV vector improves survival in a mouse model of surfactant B deficiency

  2020cites this paper
• Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses

  2018cites this paper
• Surfactant Protein B Deficiency Caused by Homozygous C248X Mutation—A Case Report and Review of the Literature

  2015cites this paper
• Structure-function relationships in pulmonary surfactant membranes: from biophysics to therapy.

  2014cites this paper
• Hematopoietic Progenitors and Precursor Cells by Adenovirus Vectors High-Efficiency Gene Transfer Into Ex Vivo Expanded Human

  2013cites this paper
• Adenoviral therapy is more effective in gemcitabine-resistant pancreatic cancer than in gemcitabine-sensitive cells.

  2011cites this paper
• 3.312 – Cell Culture Systems for Studying Biomaterial Interactions with Biological Barriers

  2011cites this paper
• Gemcitabine synergistically enhances the effect of adenovirus gene therapy through activation of the CMV promoter in pancreatic cancer cells

  2010cites this paper
• hTERT‐promoter‐dependent oncolytic adenovirus enhances the transduction and therapeutic efficacy of replication‐defective adenovirus vectors in pancreatic cancer cells

  2010cites this paper
• Pharmacological targets for gene therapy in lung inflammation

  2009cites this paper
• Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer

  2009cites this paper
• Up‐regulation of integrin β3 in radioresistant pancreatic cancer impairs adenovirus‐mediated gene therapy

  2009cites this paper
• Acquired Nonneoplastic Neonatal and Pediatric Diseases

  2008cites this paper
• Chapter 13. Endobronchial Gene Therapy

  2008cites this paper
• Radiation Enhances Adenoviral Gene Therapy in Pancreatic Cancer via Activation of Cytomegalovirus Promoter and Increased Adenovirus Uptake

  2008cites this paper
• Gene therapy of surfactant protein B deficiency.

  2006cites this paper
• Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival

  2006cites this paper
• Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered

  2006cites this paper
• Adenoviral vector–mediated gene transfer of IL‐13Rα2 chain followed by IL‐13 cytotoxin treatment offers potent targeted therapy for cytotoxin‐resistant cancers

  2005cites this paper
• Cell Culture Models of the Respiratory Tract Relevant to Pulmonary Drug Delivery

  2005cites this paper
• Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant adenoviral NK4 in nude mice

  2005cites this paper
• Endobronchial gene therapy.

  2004cites this paper
• Potential genetic therapies for acute lung injury.

  2004cites this paper
• Chapter 107 – Genetics and Physiology of Surfactant Protein Deficiencies

  2004cites this paper
• Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation model

  2004cites this paper
• Utilization of adenovirus vectors for multiple gene transfer applications.

  2004cites this paper
• Bronchoscopic-Mediated Gene Therapy: Past, Present and Future

  2004cites this paper
• Endobronchial Gene Therapy

  2004cites this paper
• Gene transduction of NK4, HGF antagonist, inhibits in vitro invasion and in vivo growth of human pancreatic cancer

  2004cites this paper
• 85 – Genetics and Physiology of Surfactant Protein Deficiencies

  2003cites this paper
• CXC chemokines and their receptors are expressed in type II cells and upregulated following lung injury.

  2003cites this paper
• Preliminary reports Tumor suppression effect using NK4, a molecule acting as an antagonist of HGF, on human gastric

  2002cites this paper
• Tumor suppression effect using NK4, a molecule acting as an antagonist of HGF, on human gastric carcinomas

  2002cites this paper
• Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy.

  2002cites this paper
• Gene Therapy and Gene Transfer Approaches for Acute Lung Injury

  2002cites this paper
• Acute hyperoxic lung injury does not impede adenoviral-mediated alveolar gene transfer.

  2002cites this paper
• Isolation and Culture of Pulmonary Alveolar Epithelial Type II Cells

  2002cites this paper
• Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice

  2002cites this paper
• RATIONALE FOR THE USE OF GENE THERAPY FOR CRITICAL ILLNESS

  2001cites this paper
• Gene therapy for acute diseases.

  2001cites this paper
• Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs

  2000cites this paper
• Characterization of Cyp2d22, a novel cytochrome P450 expressed in mouse mammary cells.

  2000cites this paper
• Administration of wild-type p53 adenoviral vector synergistically enhances the cytotoxicity of anti-cancer drugs in human lung cancer cells irrespective of the status of p53 gene.

  2000cites this paper
• Gene Therapy for Lung Disease: Hype or Hope?

  2000cites this paper
• Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis

  2000cites this paper
• Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs

  1999cites this paper
• Upregulation of Fibrinolysis by Adenovirus-Mediated Transfer of Urokinase-Type Plasminogen Activator Genes to Lung Cells in Vitro and in Vivo

  1999cites this paper
• High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors.

  1998cites this paper
• Intermittent, repetitive corticosteroid-induced upregulation of platelet levels after adenovirus-mediated transfer to the liver of a chimeric glucocorticoid-responsive promoter controlling the thrombopoietin cDNA

  1998cites this paper
• Regulation and function of pulmonary surfactant protein B.

  1998cites this paper
• In vivo human carboxylesterase cDNA gene transfer to activate the prodrug CPT-11 for local treatment of solid tumors.

  1998cites this paper
• Adenovirus-mediated expression of an elastase-specific inhibitor (elafin): a comparison of different promoters

  1998cites this paper
• Gene Therapy for the Acute Respiratory Distress Syndrome

  1998cites this paper
• Adenovirus vector-mediated perforin expression driven by a glucocorticoid-inducible promoter inhibits tumor growth in vivo.

  1998cites this paper
• Genetics of the hydrophobic surfactant proteins.

  1998cites this paper
• Intermittent, repetitive corticosteroid-induced upregulation of platelet levels after adenovirus-mediated transfer to the liver of a chimeric glucocorticoid-responsive promoter controlling the thrombopoietin cDNA.

  1998cites this paper
• Neonatal respiratory distress in near‐term infants—consider surfactant protein B deficiency

  1997cites this paper
• In vivo gene therapy of murine melanoma mediated by recombinant vaccinia virus encoding human IL-2 gene.

  1997cites this paper
• Anti-inflammatory therapies: application of molecular biology techniques in intensive care medicine

  1997cites this paper
• Human adenovirus vectors for gene transfer into mammalian cells.

  1997cites this paper
• Viral‐mediated gene transfer in the cochlea

  1997cites this paper
• Surfactant protein-B deficiency.

  1997cites this paper
• Gene therapy in pediatric medicine.

  1996cites this paper
• Protéinose alvéolaire néonatale et déficit en SP-B : le surfactant pulmonaire à l'ère de la pathologie moléculaire

  1996cites this paper
• Gene therapy approaches for inherited and acquired lung diseases.

  1996cites this paper
• [Neonatal pulmonary alveolar proteinosis and SP-B deficiency: pulmonary surfactant at the time of molecular pathology].

  1996cites this paper
• Respiratory epithelial cell culture models for evaluation of ion and drug transport

  1996cites this paper
• Transduction of human trophoblast cells by recombinant adenoviruses is differentiation dependent.

  1996cites this paper
• In Vivo Replication-Deficient Adenovirus Vector-Mediated Transduction of the Cytosine Deaminase Gene Sensitizes Glioma Cells to 5-Fluorocytosine

  1996cites this paper
• Surfactant Protein A-Producing Cells in Human Fetal Lung Are Good Targets for Recombinant Adenovirus-Mediated Gene Transfer

  1996cites this paper
• In Vivo Adenovirus-Mediated Gene Transfer of the Escherichia coli Cytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-Fluorocytosine

  1995cites this paper
• The use of adenoviral vectors for gene therapy and gene transfer in vivo.

  1995cites this paper